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Motto: “If any neurologic surgeon were asked to name the most difficult tumor to 
extirpate, his answer would doubtless to be the acustic tumor”  
Dandy (1) 
 
Abstract 
Background: The main objective in 
treating large and giant vestibular 
schwannomas (VS) (large - diameter 
exceeding 3.5 cm and giant - diameter 
exceeding 4.5 cm) is their complete 
removal without significant morbidity. Our 
experience on 7 cases (4 females, 3 males, 
mean age 42.5 years) with marked 
brainstem compression, operated between 
2004-2009 focuses on factors influencing 
recurrence and morbidity, especially related 
to facial nerve function. These patients 
were included in a series of 32 consecutive 
vestibular schwannoma excisions. 
Methods: This report is a retrospective 
analysis of the surgical outcome of 7 
patients with large and giant VS using the 
retrosigmoid-transmeatal approach. Several 
prognostic factors were evaluated: patient 
age, tumor size and consistency, extent of 
surgical removal, concurring 
hydrocephalus, hearing loss, facial nerve 
function, trigeminal nerve deficits, cranial 
nerve VI, IX and X palsy, tongue edema, 
ataxic gait and motor deficits. 
Results: The mean age was 42.3 years, the 
mean tumor diameter was 51.8 mm. There 
were no deaths and the tumors were 
histologically benign. Extensive 
microscopic tumor resection was 
performed in 5 cases related to solid 
tumor’s consistency. Preoperatively hearing 
loss and high intracranial pressure were 
encountered in all patients. 4 patients had 
cerebellar ataxia. Facial anatomical 
continuity was preserved in 6 cases with 
solid tumor consistency; 4 patients had a 
preoperative facial palsy, a good facial nerve 
function was achieved in 3 cases – House-
Brackmann grade I/II. We have met other 
distinctive signs: cranial nerve V 
hypoesthesia, VI, IX and X palsy, tongue 
edema in 2 cases with slight contralateral 
motor deficit. All patients were clinical and 
MRI monitored at 3, 6 and 12 months 
postoperatively. 
Conclusion: Total resection associated 
with a low morbidity rate is possible, 
avoiding recurrence, reintervention and 
severe scar tissue. In cases with subtotal 
resection, radiosurgery is recommended to 
improve outcome. 
Keywords: large and giant vestibular 
schwannomas (VS), surgical approach, 
facial nerve function 
Introduction 
The progress of neurosurgery as a 
specialty is related to the history of a 
vestibular schwannoma (VS) – the more 
accurate term of the classical acoustic 
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neuroma, suggesting the tumor origin from 
the superior (upper) division of the 
vestibular nerve, not from the cochlear (also 
known as the acoustic) nerve (2). 
Microsurgical removal of large and giant 
VS is a daunting task to surgeons, 
presenting a greater challenge in the quest 
for total removal - based on a clear surgical 
strategy, functional cranial nerve 
preservation and avoidance of any 
complications (3-8). 
For VS larger than 3 cm, associated with 
significant compression of the brainstem, 
Gamma knife therapy cannot be used 
because of the need to program more than 
one isocenter for the radiation dose, 
exposing normal neural tissue to excess 
amounts of radiation (5)(9). 
We have made a retrospective analysis of 
the surgical outcome of 7 patients with 
large and giant vestibular schwannomas 
operated using the retrosigmoid-
transmeatal approach. 
Material and methods 
From 2004-2009, 32 consecutive VS 
resections were performed by the senior 
author (G.I.) using the retrosigmoid-
transmeatal approach. Inclusion criteria 
were all VS larger than 3 cm in size, 
corresponding to grade IV Koos 
classification. We have identified in a review 
of the operations 7 cases with large or giant 
VS: 4 females, 3 males, mean age 42.5 years 
(ranging from 38-68 years). 
Preoperative hearing loss - the threshold 
retained for useful hearing was 60 decibel – 
Norstadt classification for audiometric 
hearing (10) and high intracranial pressure 
with obstructive hydrocephalus were 
encountered in 2 patients. 4 patients 
(57.14%) had cerebellar ataxia; 5 patients 
(71.42%) had facial numbness, paresthesia; 
4 (57.14%) patients had a preoperative facial 
palsy; 3 (42.8%) patients had swallowing 
difficulties and contralateral motor deficit 
was observed in 2 (28.57%) patients  
All patients underwent CT, MRI T1 - 
weighted imaging before and after 
Gadolinium (Gd ) administration and T2 – 
weighted imaging pre and postoperative; 
measurements were made on the largest 
diameter of the tumor excluding 
intracanalicular components. Tumors 
classified as large presented a diameter 
above 3.5 cm, whereas the diameter of giant 
tumors exceeded 4.5 cm. There were 4 
(57.14%) cases with giant tumors and 3 
(42.85%) cases with large tumors (mean 
tumor diameter was 51.8 mm). The 
tumor’s consistency was classified as solid 
or cystic using T1 and T2 – weighted image 
with Gd administration. We found that 
28.5% of VS (2 cases) included in our study 
contained cystic elements.  
Surgery was performed using the 
retrosigmoid – transmeatal approach in the 
lateral decubitus. In 2 cases a temporary 
shunt was placed intraoperatively to relieve 
hydrocephalus. A retrosigmoid suboccipital 
craniotomy of 4 cm diameter was made to 
expose the posterior part of the sigmoid 
sinus and the inferior part of the transverse 
sinus. We favor such an approach for the 
following arguments: a wider field of 
action, direct visualization of anterior 
inferior cerebellar artery (AICA) and other 
brain stem vessels, dissection of all surfaces 
of the acoustic tumor always under direct 
vision, identification of the facial nerve in 
the lateral angle of the internal auditory 
canal, ready access to the facial nerve when 
either anastomosis or graft reconstruction 
may be necessary. 
The surgical technique was based on 
internal tumor debulking made in a 
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systematic fashion. The ultimate goal of VS 
surgery being cranial nerves preservation, 
tumor removal is merely a byproduct. The 
surgical steps after dural opening tangent to 
sinuses are:  
-cisterna magna opening to allow 
cerebellar retraction, made by applying a 
single broad malleable blade from below 
upwards 
-identification of the double arachnoid 
membrane protecting the cerebellum, 
lower cranial nerves, anterior inferior 
cerebellar artery (AICA) 
-the tumor capsule is separated from the 
cerebellum and the inferior tumor part is 
elevated from the lower cranial nerves and 
brain stem 
-centrifugal, rapid, tumor debulking, to 
shrink tumor using tumor forceps, 
dissector (CUSA may perforate the 
arachnoid layer and damage the neural 
vasculature!); it’s better to leave a shelf of 
tumor “capsule” all around to avoid injury 
to all structures outside it 
-the tumor is further separated at the 
upper pole from the trigeminal nerve and 
pons 
-the meatus acusticus internum is 
exposed in two stages: drilling away the 
back wall, carrying out the remaining upper 
tumor; optional drilling the fundus. It is 
mandatory to avoid the semicircular canals 
(laterally) and the jugular bulb (inferiorly) 
whilst drilling; copious water irrigation 
whilst canal drilling to prevent thermal 
injury to VII & VIII complex; stripping the 
dura from canal; waxing bone edges to keep 
the field bloodless; placement of muscle 
patch in IAC after tumor removal to 
prevent CSF leak  
-fine dissection close to nerves - the 
remainder is separated from the facial 
nerve, brain stem, abducens nerve using a 
water-jet dissection. In our series, the facial 
nerve was displaced over the medial aspect 
of the tumor. Dissection was made 
bidirectional from the medial and lateral 
direction meeting near the meatus 
acousticus internum where most 
adherences are to be seen. A small part of 
the capsule attached to the nerve should be 
leaved. Several blood vessels should be 
preserved: internal auditory artery, AICA 
and its branches – the most displaced vessel, 
SCA, brain stem perforators; also the 
petrosal and mesencephalic veins. 
-dura is closed watertight using a wet 
fibrinoid-based collagen fleece 
(Tachocomb), bone flap is refixed. 
-for extensive adherences of the tumor 
to the facial nerve and also to the brainstem 
in 2 (28.57%) cases a partial tumor removal 
was performed; no bipolar coagulation was 
used for hemostasis in this situation: 
applying a cottonoid, a Gelfoam or Surgicel 
is temporarily sufficient. Trauma to 
arachnoidless brain stem surface can be 
predicted on pre-op CT/MRI. Possible 
postoperative complications could be 
induced by: forceful retraction of a densely 
adherent tumor, traction on the bridging 
vessels wich may lead to intra-pontine 
hemorrhage and coagulation of perforators 
that can induce brain stem infarction. To 
avoid such complications, tumor feeders 
should be coagulated and sectioned where 
they enter the tumor; also staying within 
the tumor arachnoid holds the key. 
Functional outcome was measured using 
the Karnofsky scale at 3, 6, 12 months 
postoperatively. Several prognostic factors 
were evaluated: patient age, tumor size and 
consistency, extent of surgical removal, 
concurrent hydrocephalus, hearing loss, 
facial nerve function according to House-
Brackmann scale, trigeminal nerve deficits, 
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cranial nerve VI, IX and X palsy, tongue 
edema, ataxic gait, motor deficits. 
Results 
Extensive microscopic tumor resection 
was performed in 5 (71.42%) cases; 
diagnosis was confirmed by histopathology 
in all cases. There were no deaths and the 
tumors were histological benign (Figure 1). 
Partial tumor removal was performed for 2 
cystic tumors were the arachnoidal plane 
was poorly defined, with severe adherences 
to brainstem and facial nerve, extensive 
bleeding and cerebellar edema. 
Facial nerve anatomical continuity was 
preserved in 6 (85.71%) cases with solid 
tumor consistency and a good facial 
function was achieved in 3 (42.85%) cases - 
House Brackmann grade I/II. For 4 
(57.14%) patients with giant VS, the facial 
nerve deficit worsened postoperatively with 
respect to House-Brackmann grading scale 
by III grades, the face was rehabilitated with 
plastic surgery techniques. 
We have noticed a rapid tumor growth, 
short symptom duration and facial nerve 
involvement in 2 cystic tumors were a 
partial resection was performed. 
The Karnofski score at discharge was 
superior to 80%. The major complications 
in this series were: 3 (42.85%) patients with 
cranial nerve V hypoesthesia, 5 (71.42%) 
patients with increased facial numbness, 4 
(57.14%) patients with transient VI, IX and 
X palsy, tongue edema and 2 (28.57%) cases 
with contralateral motor deficit. These 
patients recovered well within 6 months 
after operation. 
In 2 cases with partially resected cystic 
tumors, at 12 months after the operation we 
have noticed on CT and MRI the same 
dimensions of the tumor remnants. 
 
             
 
 
   
 
       
 
Figure 1 Preoperative cerebral CT showing giant VS (51 mm) with obstructive hydrocephalus (A-C); 
postoperative cerebral CT after 1 year follow-up showing complete resection (D, E); another case with giant VS 
(57 mm) showing pre and postoperative CT 
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Discussion 
VS are typically slow growing, benign 
skull base tumor of cerebellopontine angle, 
with natural unpredictable evolution and 
annual growth rate between 0.2-2 mm; they 
originate from the intracanalicular part of 
the vestibular nerve, in the region of the 
transition zone between central and 
peripheral myelin (2).  
While VS was first described by Eduard 
Sandifort in 1777, the first successful 
surgical removal was achieved by Sir 
Charles Balance in 1894, cited by (2). 
Several neurosurgical pioneers made major 
advancements in managing this usually 
benign skull base tumor: F. Krause who 
introduced the retrosigmoid approach to 
the cerebellopontine angle and H. Cushing 
who advocated for subtotal removal and 
was the first to reduce mortality from 50 to 
7.7% - cited by (11). W. Dandy (1) 
recommended total excision with 
meticulous capsule dissection as goal of 
surgery in order to prevent recurrences, 
with an acceptable low mortality of 2.4%. In 
1967 Olivecrona (12) proposed to preserve 
the facial nerve, achieving this in 20% of his 
304 patients with a total tumor removal in 
217 patients and a mortality rate rising up to 
23%.  
The translabyrinthine approach was 
adopted by Panse in 1904 - cited by (2) as a 
method to achieve tumor removal 
preserving the facial nerve. In 1964 House 
(13) introduced operating microscope for 
translabyrinthine approach and in 1965 
Rand and Kurze - cited by (2) were the first 
to introduce an operating microscope for 
the transmeatal posterior fossa approach.  
Yasargil (14) improved the microsurgical 
technique, emphasizing the importance of 
the brain stem arterial supply and the need 
to optimize the preservation of facial nerve 
function. These technical advances have led 
to a 50% reduction in mortality, a rate of 
complete tumor removal reaching 85% and 
to a successful anatomical preservation of 
the facial nerve in 80% of the cases. 
The management of VS has evolved 
significantly with the advent of new 
radiological diagnostic procedures (high 
resolution CT, multiplanar MRI) that allow 
early diagnosis of small and medium size 
VS; safe, modern anesthesia, development 
and refinements in the microsurgical 
techniques, neurophysiological 
intraoperative monitoring and working in 
multidisiplinary teams have led to a 
dramatic improvement in clinical outcome, 
with an operative mortality of around 1% 
and a rate of total tumor removal close to 
95% (2-9)(15-24).  
In some expert hands: Koos W. (18), 
Rhoton Al. (21), Samii M. (2)(6), Noren 
G., Regis J., Pellet W., Cannoni M. – cited 
by (11), the preservation of useful hearing 
(Gardner-Robertson 1 or 2) has been 
achieved in selected small lesions with very 
good preoperative hearing and also the 
possibility of preserving normal facial 
motor function in many cases (House-
Brackman 1 or 2). 
Although surgical procedures could be 
complex and difficult, even in large and 
giant VS compressing the brainstem, a 
complete tumor removal has become the 
rule in many cases, preserving all cranial 
nerves in exceeding numbers, without 
additional morbidity or mortality. In many 
cases the VIIth nerve may be so thin that it 
could be be confused with the arachnoid 
when very severely compressed. There are 
various anatomical relationships 
encountered during resection; nerve 
stimulator, electrophysiology may allow a 
gentle separation of VII nerve from tumor 
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by using micro dissector & sharp arachnoid 
dissection (6)(7)(18). 
Brainstem compression, even brainstem 
dislocation, cerebellum and severe fourth 
ventricle compression can produce 
ventricular dilatation; the VII & VIII 
complex, lower cranial nerves severely 
stretched occur in large or giant VS 
(10)(18). 
The most common clinical signs (5) are: 
cophosis, cerebellar ataxia, symptoms of 
raised intracranial pressure (headache, 
papilledema) and symptoms of normal 
pressure hydrocephalus in elderly (gait 
disturbance, dementia and incontinence). 
In our series a temporary shunt was placed 
intraoperatively to relieve hydrocephalus in 
2 cases; generally the need of a preoperative 
shunt was as high as 66% in ancient series 
(14), others consider shunting rarely 
required because total surgical excision is 
sufficient (7). 
The approach is controversial: many 
surgeons prefer the retrosigmoid approach 
in the sitting, semi-sitting or lateral position 
(2-8)(15)(17-19)(21)(23). However Sami 
(6) reported a high incidence of hematoma 
after retrosigmoid removal of cystic tumors 
in the semisitting position, as well as air 
embolism irrespective of anesthetic 
monitoring measures taken to prevent this 
complication. In the lateral position the 
peritumoral veins may generate 
intraoperative bleeding (5). The 
translabyrinthine approach is advocated by 
ENT surgeons for good tumor exposure 
with minimal retraction of the cerebellum, 
early facial nerve identification and eases 
the repair of the facial nerve when it is 
transected (5)(13)(15)(16)(20)(24)(25). The 
disadvantages of the translabyrinthine 
approach (4) are: longer operating times, 
higher rates of postoperative facial paralysis 
and the risk of cerebrospinal fluid leak.  
In large VS, Anderson (3) described a 
combined translabyrinthine-retrosigmoid 
approach especially for more lateral giant 
tumors that extend to the fundus of the 
IAC. The rates of preserving good facial 
nerve function are similar among the 
retrosigmoid, translabyrinthine and middle 
fossa approaches in large VS: 42-52.6% with 
early identification of the root entry/exit 
zone and caution in tumor excision in the 
extrameatal region just outside the porus 
acusticus (5). Only 18% of operated 
patients have excellent facial nerve function 
(House-Brackmann grade I/II) explained by 
the bad initial clinical status, the tumor size 
and the lack of systematic intraoperative 
facial monitoring (5)(8)(17)(19)(23). 
According to  Sami (6) facial nerve 
anatomical results (of 200 cases of grade T4 
VS, total removal was achieved in 98% and 
anatomical facial nerve preservation was 
possible in 98,5%) were not correlated with 
functional results, while size was well 
correlated with facial function. Even when 
the facial nerve is left anatomically intact, 
surgical interventions can have esthetic and 
functional consequences which greatly 
reduce the quality of life (4). 
Removal of large and giant residual or 
recurrent VS is more difficult due to scar 
tissue and the absence of a clear arachnoid 
plane between tumor and brainstem, 
vessels, and nerves even for the most 
experienced surgeon (11,18). When 
excision is incomplete, the recurrence rate 
is usually high, depending of VS cellularity 
and vascularisation (7). Recurrence rate 
reported was of 0-3.9% for gross total 
removal; 9.4-29% for near total resection as 
a result of surgical devascularization and 
25-65% for subtotal resection, especially in 
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the midcerebellopontine angle after the 
translabyrinthine approach (24). Vestibular 
schwannomas can relapse 10-15 years 
postoperatively (10% of patients) even 
when surgeons have the impression that 
these have been completely removed (4). 
The growth rate of residual or recurrent VS 
is unpredictable: most authors reported a 
very low recurrence rate after complete 
tumor excision; however, a higher 
recurrence rate after subtotal removal has 
also been observed in 44-53% of patients 
(5). In cystic tumors (26) a rapid tumor 
growth with possible vascular compression 
led to a less favourable outcome than solid 
tumor, also some tumor remnants may not 
grow. Also cystic VS demand careful 
dissection and may be subtotally resected 
for various reasons: the arachnoid plane is 
not easily preserved as it is densely adherent 
to the surrounding structures; the cranial 
nerves are displaced in a relatively uncertain 
position; cyst formation may predict a more 
intimate involvement of the neural tissue; 
high tendency to postoperative bleeding; 
dissection of the facial nerve from the 
tumor is more difficult (5)(6)(22).  
For subtotal tumor debulking confirmed 
by MRI at 3 months, 6 months to 1 year 
postoperatively, the alternatives are 
(5)(6)(9)(17)(22)(26):  
-planned staged approaches – first tumor 
debulking via a retrosigmoid approach 
followed by a second stage translabyrinthine 
resection of the residual tumour 
-wait and see – in case a a small and 
stable residual tumor in elderly patients  
-subtotal tumor debulking followed by 
stereotactic radiotherapy which can offer 
excellent facial nerve function in 85.7% 
patients with House-Brackmann grade I/II 
(1) and tumor growth control. At the time 
of radiosurgery the tumor size is 
diminuished < 20 mm and radiosurgery 
could be made with a peripheral dose 11-13 
Gy and in the tumor centre the dose should 
be 22-26 Gy. 
Conclusion 
VS is a benign tumor in a malignant 
location (2). Progressive improvement in 
the results of VS surgery was possible 
owing to: better clinical preoperative 
deficits evaluation, tumor size (the smaller 
the tumor, the better the outcome !), 
imaging innovations, intensive care, 
intraoperative monitoring, advent of 
microsurgery and of course increasing 
surgical experience (6-8)(18). 
Complete VS removal at one stage while 
preserving neurological functions and the 
quality of life should be the optimal 
treatment, thus avoiding recurrency, 
reintervention and severe scar tissue.  
For large and giant VS the optimal 
treatment should be tried; however an 
alternative could be the combined staged 
therapy: subtotal intracapsular resection 
relieving mass effect and brainstem 
compression at the first stage, follow-up 
and stereotactic radiosurgery at a second 
stage for the residual tumor. 
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